1st Aug 2014 17:01
- FTSE ended 50.93 points lower at 6,679.18 - UK, Eurozone PMI comes in weak - US jobs increase by 209,000 techMARK 2,751.56 -0.48% FTSE 100 6,679.18 -0.76% FTSE 250 15,402.70 -0.60% The FTSE ended significantly lower as weak Eurozone and UK manufacturing data, US jobs figures and broker downgrade
Read more1st Aug 2014 10:33
AstraZeneca: Deutsche Bank ups target price from 3950p to 4000p staying with its hold recommendation. Avacta: Numis places both its target price and its buy recommendation under review. Barclays: Berenberg upgrades from sell to hold with a target price of 220p. Bodycote: UBS shifts target price f
Read more1st Aug 2014 09:15
- Miners, RBS drag markets lower - US labour-market data in focus - UK stocks follow sell-off on Wall Street techMARK 2,747.58 -0.63% FTSE 100 6,688.51 -0.62% FTSE 250 15,393.35 -0.66% Falling share prices in the mining sector and a cool reaction to quarterly results from Royal Bank of Scotland en
Read more1st Aug 2014 08:30
First half profits at engineering group IMI were hit by the impact of the strength of sterling on revenue, as anticipated. Turnover fell 3% from £831m to £809m year-on-year, saying foreign exchange movements reduced revenue by £45m. Organic revenue was 3% higher. The operating margin declined by 6
Read more24th Jul 2014 08:59
Afren: JP Morgan shifts target price from 180p to 188p upgrading from underweight to overweight. Anglo American: Jefferies raises target price from 1550p to 1700p and reiterates a hold recommendation. Antofagasta: Jefferies increases target price from 825p to 1000p upgrading from hold to buy. ARM
Read more22nd Jul 2014 09:37
Abcam: N+1 Singer places both its target price (prev.: 346p) and its sell recommendation under review. Amiad Water Systems: Oriel lowers target price from 350p to 340p and retains a buy recommendation. Ashmore Group: Espirito Santo ups target price from 371p to 404p, while downgrading to neutral.
Read more18th Jun 2014 15:24
Shire's shares have spiked higher on rumours that Allergan could bid for the company in an effort to fend off a hostile takeover attempt by Valeant Pharmaceuticals. Bloomberg cited an analyst at SunTrust Robinson Humphrey who said that a bid is "imminent" and "makes strategic sense" for the US compa
Read more4th Jun 2014 09:28
Advanced Computer Software: Panmure Gordon ups target price from 139p to 155p and stays with its buy recommendation. Avacta: Numis shifts target price from 1.9p to 2p and retains a buy recommendation. Balfour Beatty: Westhouse Securities reduces target price from 302p to 220p keeping its neutral r
Read more29th May 2014 16:59
- FTSE 100 closes up 20 at 6,871 - US Q1 GDP comes in below expectations - Smith & Nephew in focus techMARK 2,809.39 +0.34% FTSE 100 6,871.29 +0.29% FTSE 250 15,954.82 +0.12% UK stocks settled higher after rising early on and staying fairly steady throughout the afternoon, despite the release of a
Read more29th May 2014 15:35
Medical device maker Smith & Nephew was a high riser again after reports yesterday suggested that US peer Stryker was working on a bid for the firm. While the rumours were denied by Stryker, Smith & Nephew's share price was continuing to extend gains this morning after Credit Suisse said it sees "me
Read more29th May 2014 12:47
Broker Oriel said Lloyds Banking Group's offloading of TSB should enhance net interest margin for the bank and, with a rising dividend yield, has reiterated its 'buy' recommendation on the bank. "This improvement should become apparent once TSB is deconsolidated, which will depend on how quickly Ll
Read more29th May 2014 11:45
- FTSE 100 nears two-week high, S&P 500 to retest records - US GDP revisions due out this afternoon - Smith & Nephew extends gains amid M&A speculation - Kingfisher disappoints with Q1 results techMARK 2,815.99 +0.58% FTSE 100 6,872.56 +0.31% FTSE 250 16,017.89 +0.52% UK stocks were heading toward
Read more29th May 2014 11:33
IMI was trading higher on Thursday after Swiss bank UBS lifted its rating on the stock from 'neutral' to 'buy', saying that growth rates of sales at the engineering group have the potential to double in the medium term. "An organic sales compound annual growth rate (CAGR) of 3% over the last decade
Read more29th May 2014 08:13
AMEC: Berenberg initiates with a target price of 1450p and a buy recommendation. Imagination Technology: UBS ups target price from 200p to 250p and maintains a buy recommendation. IMI: UBS raises target price from 1600p to 1700p upgrading from neutral to buy. John Wood Group: Berenberg initiates
Read more9th May 2014 08:44
Advanced Medical Solutions: Numis ups target price from 105p to 121p and retains its hold recommendation. Arrow Global: Numis upgrades from add to buy with a target price of 285p. Bank of Georgia: Numis downgrades from buy to hold with a target price of 2708p. Barclays: Citi lowers target price f
Read more